Top Story

Antivirals improve CMV pneumonia outcomes after HCT

March 30, 2015

Outcomes of cytomegalovirus pneumonia after hematopoietic cell transplantation have improved modestly over the past 25 years largely due to antiviral treatment and changes in transplantation protocols rather than the use of adjunctive immunoglobulin treatment, according to recent findings.

“Although the development of effective cytomegalovirus (CMV) prevention strategies has significantly reduced the need to treat established CMV disease after hematopoietic cell transplantation (HCT), the management of CMV pneumonia remains a formidable challenge,” the researchers wrote. “Furthermore, late CMV disease may occur after both myeloablative and non-myeloablative HCT.”

FDA News

FDA grants priority review for expanded use of Kyprolis in relapsed multiple myeloma

March 30, 2015
The FDA today accepted the supplemental new drug application of carfilzomib for the treatment of patients with relapsed multiple myeloma who have received at least one…
Dennis Slamon Industry News

Panel of cancer experts highlight advancements in precision medicine

March 30, 2015
Advancements in the understanding of cancer genetics have led to important breakthroughs in precision medicine, according to a Columbia University media briefing on the…

Experts discuss whether shift in Medicare will reduce costs, improve quality of care

March 30, 2015
In response to concerns over Medicare’s current fee-for-service payment system, the Obama administration announced in January that by 2018 Medicare instead will…

Tumor profiling model finds potential therapeutic agents for HCC

March 30, 2015
In a retrospective study, researchers used Caris Molecular Intelligence to identify molecular patterns and therapeutic options for hepatocellular carcinoma and presented…
More News Headlines »
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
thumbnail for video 4126759064001

Solid organ transplant recipients at higher risk for skin cancer

March 22, 2015
SAN FRANCISCO – In this video, Sarah Tuttleton Arron, MD, PhD, FAAD, discusses her research on mortality from…
More »
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »